The founder of Gliimpse, Anil Sethi, said on LinkedIn that he created the app because "there's no single electronic health record that all physicians use ... Worse, there isn't even a common file format across 1,000+ systems." As such, the app is primarily targeted at patients with complex health records, particularly those who suffer from chronic illnesses like diabetes, cancer and heart problems.

Apple's HealthKit is used by half the hospitals in the US to monitor patients with serious health issues. The aim is to help researchers conduct trials to gauge the effectiveness of treatments for serious and chronic diseases. Since Gliimpse collects confidential patient data with "rigorous technical security," the acquisition makes sense. However, it could be awhile before we see exactly how Apple brings it into the fold.